[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Alzheimer's Light LLC\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":69},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,45],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100371332","longitudinal-cognitive-assessment-by-boca-100371332",false,"NCT04114994","Longitudinal Cognitive Assessment by BoCA","BoCA","Inclusion Criteria:\n\nage 50 or older\n\nExclusion Criteria:\n\nyounger than 50 years",true,"ALL","50 Years",{"count":20,"type":21},10000,"ESTIMATED","OBSERVATIONAL","The Boston Cognitive Assessment (BoCA) is a self-administered online test intended for longitudinal cognitive monitoring. BoCA uses random not-repeating tasks to minimize learning effects. BoCA was developed to evaluate the effects of treatment in longitudinal clinical trials and available gratis to individuals and professionals.",[25,26,27,28,29,30,31],"Alzheimer Disease","Mild Cognitive Impairment","Vascular Dementia","Frontotemporal Dementia","Parkinson Disease","Multiple Sclerosis","TBI","RECRUITING","2024-07-31",{"date":35,"type":36},"2024-08-01","ACTUAL",{"date":38,"type":36},"2019-10-01",{"date":40,"type":21},"2029-10-01",{"name":42,"class":43},"Alzheimer's Light LLC","INDUSTRY",1,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":51,"eligibilityCriteria":52,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":53,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":55,"conditions":56,"keywords":61,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":63,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":44},"100336232","alzheimers-disease-treatment-with-combination-of-40hz-light-and-cognitive-therapy-100336232","NCT03657745","Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy","An Observational Trial of Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy","AlzLife","Inclusion Criteria:\n\n* Alzheimer's disease\n* Cognitive Impairment\n\nExclusion Criteria:\n\n* any previously noted epileptic seizures, including febrile seizures.\n* any significant disease of the eye, such as macular degeneration. Since the 40Hz light therapy is delivered via eye stimulation, healthy eyes are required.",{"count":54,"type":21},2000,"Electrical activity in the brain known as \"gamma\" brainwaves help connect and process information throughout the brain. These gamma waves are diminished in Alzheimer's disease. New research in Alzheimer's disease mouse models shows that exposure to light flickering at the rate of 40 flashes per second or 40Hz increased gamma brainwaves and led to clearing of beta amyloid plaques in the brain, a key abnormality in Alzheimer's disease. This project will test the ability of a novel iPad App (AlzLife https:\u002F\u002Fwww.alz.life\u002F) that delivers light therapy at 40 Hz combined with cognitive therapy to improve cognition, function, and quality of life in Alzheimer's disease.",[25,26,57,58,59,60],"Dementia","Cognition Disorders in Old Age","Cognitive Decline","Cognitive Deterioration",[25,62,57],"Alzheimer's",{"date":35,"type":36},{"date":65,"type":36},"2018-01-01",{"date":67,"type":21},"2029-12-31",{"name":42,"class":43},""]